IKT – inhibikase therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

IKT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/24

03:47 pm

ikt

Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.

Low Report

Form 4 Inhibikase Therapeutics, For: Nov 21 Filed by: Sands Capital Life Sciences Pulse Fund II, L.P.

Report

11/21

04:28 pm

ikt

Form 8-K Inhibikase Therapeutics, For: Nov 20

Medium Report

Form 8-K Inhibikase Therapeutics, For: Nov 20

Report

11/21

04:24 pm

ikt

Form 424B5 Inhibikase Therapeutics,

Medium Report

Form 424B5 Inhibikase Therapeutics,

Report

11/20

04:35 pm

ikt

Form 424B5 Inhibikase Therapeutics,

Medium Report

Form 424B5 Inhibikase Therapeutics,

Report

11/20

04:12 pm

ikt

Form 8-K Inhibikase Therapeutics, For: Nov 20

Medium Report

Form 8-K Inhibikase Therapeutics, For: Nov 20

Report

11/14

04:43 pm

ikt

Form 10-Q Inhibikase Therapeutics, For: Sep 30

Low Report

Form 10-Q Inhibikase Therapeutics, For: Sep 30

Report

11/14

04:31 pm

ikt

Form 8-K Inhibikase Therapeutics, For: Nov 14

Low Report

Form 8-K Inhibikase Therapeutics, For: Nov 14

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.